{"id":502858,"date":"2021-06-10T16:15:54","date_gmt":"2021-06-10T20:15:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/"},"modified":"2021-06-10T16:15:54","modified_gmt":"2021-06-10T20:15:54","slug":"biogen-announces-investor-day-on-september-21-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/","title":{"rendered":"Biogen Announces Investor Day on September 21, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., June  10, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=28qIF-3vhZru7R5Yz4e2t7w773eZQ068tw2-IfQ7_svBkl54ZUT3F6H7Ag5BoTdvLJ_dLGxkWjemoRcyScGj3g==\" rel=\"nofollow noopener\" target=\"_blank\">Biogen Inc.<\/a>\u00a0 (Nasdaq: BIIB) announced today that it will hold an Investor Day focused on its broad pipeline across neuroscience and related therapeutic adjacencies. The event will be webcast live on September 21, 2021 at 10:00 a.m. ET. Further details will follow. To access the live webcast, please go to the investors section of Biogen\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NF6GAeukYX1jy-WBa8bATFAMz6gDk5Qix9y0Y39NpSJqDT24c7wSw9O6zvHoEdkp0jE9eT_VrCgJcxvzCsDi-JrF1Fw6J2lNG6ZBYwU-pPg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>invest<\/u><u>o<\/u><u>rs.biogen.com<\/u><\/a>. Following the live webcast, an archived version of the webcast will be available at the same URL.<\/p>\n<p align=\"start\">\n        <strong>About Biogen<\/strong><br \/>\n        <br \/> At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world\u2019s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer\u2019s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.<\/p>\n<p align=\"start\">We routinely post information that may be important to investors on our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SnMzjGxUZwb6aFwAsGkzRaZMP9lk-3Gu5XFEVCc2egOVpNnwWF35-yeCHeUqHgMUqjLrWL7YEuIVA69eGTPjTA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.biogen.com<\/u><\/a>. To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SnMzjGxUZwb6aFwAsGkzRVWYBk-J831Na92CSf08ckMSZZ1nRIsASgdoJnr-NOQHJJwyqabxCY9NkopRIGAVcA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.biog<\/u><u>e<\/u><u>n.com<\/u><\/a>\u00a0and follow us on social media \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=180RM6hUDFp3_nPku7_UGOjjBTdsq_eZ_PQKCB5-KhpHyk6-4NVjAwf5PU5LI692iUuUj67LZsOEzISZUHlSQg==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WydfZogG_X2wAQPb-uqMTQj0WMGM84cSku35ZnmDo9thPdVEZ_OZFrHl95_xaNsgW9BhPZR88i0gVr9a81d-sjG61Su57iQnpQWRdh0P9oY=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o0NzwW1AOcDFmOiQbL7WjZRwsCsm0Ud9JwW8TYMMYuttw1NktOmO694nwz-cjU9Z4kuJLXtAInHuLqQ_1O6xAg==\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JIpFvz3ZTU2KN6Mw0oPJfQlZfoLNI7GQqY_99OYSYn2HbeFmtKNE0HmMprogYLif7ej00TPTwNBmBQkdXafjXQ==\" rel=\"nofollow noopener\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p align=\"start\" \/>\n<p align=\"start\">\n        <u>Contact:<\/u><br \/>\n        <br \/> Karen Jewell <br \/> Investor Relations <br \/> Biogen <br \/> 781-464-2442<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/76123ca1-b16e-4337-b6c8-bfc02620bf65\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) &#8212; Biogen Inc.\u00a0 (Nasdaq: BIIB) announced today that it will hold an Investor Day focused on its broad pipeline across neuroscience and related therapeutic adjacencies. The event will be webcast live on September 21, 2021 at 10:00 a.m. ET. Further details will follow. To access the live webcast, please go to the investors section of Biogen\u2019s website at investors.biogen.com. Following the live webcast, an archived version of the webcast will be available at the same URL. About Biogen At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Biogen Announces Investor Day on September 21, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-502858","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) &#8212; Biogen Inc.\u00a0 (Nasdaq: BIIB) announced today that it will hold an Investor Day focused on its broad pipeline across neuroscience and related therapeutic adjacencies. The event will be webcast live on September 21, 2021 at 10:00 a.m. ET. Further details will follow. To access the live webcast, please go to the investors section of Biogen\u2019s website at investors.biogen.com. Following the live webcast, an archived version of the webcast will be available at the same URL. About Biogen At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One &hellip; Continue reading &quot;Biogen Announces Investor Day on September 21, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-10T20:15:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biogen Announces Investor Day on September 21, 2021\",\"datePublished\":\"2021-06-10T20:15:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/\",\"name\":\"Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\",\"datePublished\":\"2021-06-10T20:15:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-announces-investor-day-on-september-21-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biogen Announces Investor Day on September 21, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/","og_locale":"en_US","og_type":"article","og_title":"Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) &#8212; Biogen Inc.\u00a0 (Nasdaq: BIIB) announced today that it will hold an Investor Day focused on its broad pipeline across neuroscience and related therapeutic adjacencies. The event will be webcast live on September 21, 2021 at 10:00 a.m. ET. Further details will follow. To access the live webcast, please go to the investors section of Biogen\u2019s website at investors.biogen.com. Following the live webcast, an archived version of the webcast will be available at the same URL. About Biogen At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One &hellip; Continue reading \"Biogen Announces Investor Day on September 21, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-10T20:15:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biogen Announces Investor Day on September 21, 2021","datePublished":"2021-06-10T20:15:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/","name":"Biogen Announces Investor Day on September 21, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=","datePublished":"2021-06-10T20:15:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1MjU5NSM0MjM3OTU5IzIwMDk2ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-announces-investor-day-on-september-21-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biogen Announces Investor Day on September 21, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/502858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=502858"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/502858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=502858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=502858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=502858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}